Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.8 USD | +0.41% | -2.05% | +11.46% |
Business Summary
Number of employees: 645
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Precision Therapies
100.0
%
| 204 | 100.0 % | 249 | 100.0 % | +22.22% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
91.1
%
| 190 | 93.3 % | 227 | 91.1 % | +19.38% |
Rest of World
8.9
%
| 14 | 6.7 % | 22 | 8.9 % | +61.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 | |
Jeffrey Albers
CHM | Chairman | 52 | 14-07-23 |
Janet Loesberg
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Becker Hewes
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-04-30 |
Percy Carter
CTO | Chief Tech/Sci/R&D Officer | 53 | 21-05-18 |
Christina Rossi
COO | Chief Operating Officer | 48 | 18-10-28 |
Chief Tech/Sci/R&D Officer | 61 | 17-10-09 | |
Tracey McCain
CMP | Compliance Officer | 56 | 16-09-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Nicholas Lydon
FOU | Founder | 67 | 08-09-30 |
Mark Goldberg
BRD | Director/Board Member | 69 | 15-06-24 |
Daniella Beckman
BRD | Director/Board Member | 45 | 21-12-07 |
Jeffrey Albers
CHM | Chairman | 52 | 14-07-23 |
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Habib Dable
BRD | Director/Board Member | 54 | 22-06-22 |
John Tsai
BRD | Director/Board Member | 57 | 23-01-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 62,616,902 | 62,055,259 ( 99.10 %) | 0 | 99.10 % |
Company contact information
Blueprint Medicines Corp.
45 Sidney Street
02139, Cambridge
+617 374 7580
http://www.blueprintmedicines.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.46% | 6.44B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- BPMC Stock
- Company Blueprint Medicines Corporation